Drug Shortage Report for SANDOZ SUMATRIPTAN
| Report ID | 2654 |
| Drug Identification Number | 02263033 |
| Brand name | SANDOZ SUMATRIPTAN |
| Common or Proper name | SUMATRIPTAN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | SUMATRIPTAN |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 1x6bl |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2017-03-14 |
| Estimated end date | 2017-06-12 |
| Actual end date | 2017-05-12 |
| Shortage status | Resolved |
| Updated date | 2017-05-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2017-05-15 | French | Compare |
| v6 | 2017-05-15 | English | Compare |
| v5 | 2017-05-08 | French | Compare |
| v4 | 2017-05-08 | English | Compare |
| v3 | 2017-03-15 | English | Compare |
| v2 | 2017-03-14 | French | Compare |
| v1 | 2017-03-14 | English | Compare |
Showing 1 to 7 of 7